In our continued commitment to enhance the success rate and efficiency in the complex process of developing pharmaceuticals, Attana will from September 1, 2013 offer a full suite of contract research services based on our proprietary technology.
Attana has during the past decade provided customers and partners around the world with biosensor systems to improve the success rate and efficiency of their R&D processes. During the past few years the demand for contract research capabilities based on the Attana technology has grown significantly, especially with regards to the unique cell-based research capabilities of the Attana Cell 200 system. Accordingly, Attana has evaluated this demand with a few select customers and based on the success, decided to include contract research as a major part of our service offering.
Fast track to drugability - Attana Research Services are geared to quickly provide customers with biologically relevant information within crucial processes and application areas. With unparalleled knowledge of the Attana systems and technology our application specialists are uniquely qualified to assist R&D teams around the world.
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences.